Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Prosecutors Identify Insys Founder as Unindicted Co-conspirator in Opioid Case

Nate Raymond  |  

The exhibit, a Feb. 2 letter prosecutors sent to defense lawyers, was later sealed, but Reuters viewed it while it was publicly available.

Kapoor, who founded Insys in 2002 and remains a board member, stepped down in January as the company’s chairman and chief executive, a role he took on in November 2015.

ADVERTISEMENT
SCROLL TO CONTINUE

He is currently the chairman of drugmaker Akorn Inc and president of investment firm EJ Financial Enterprises Inc.

In addition to the Boston case, charges have been filed against former Insys employees and medical practitioners by federal prosecutors in states including Alabama, New York and Connecticut.

ADVERTISEMENT
SCROLL TO CONTINUE

 

Related Articles

    Former Insys CEO Pleads Guilty to Opioid Kickback Scheme

    BOSTON (Reuters)—The former chief executive of Insys Therapeutics Inc pleaded guilty on Wednesday to participating in a nationwide scheme to bribe doctors to prescribe an addictive opioid medication and has agreed to become a government witness. Michael Babich, who resigned as the Arizona-based drugmaker’s CEO in 2015, pleaded guilty in federal court in Boston to…

    Billionaire Insys Founder Charged in U.S. Opioid Bribe Case

    BOSTON (Reuters)—The billionaire founder of Insys Therapeutics Inc was arrested on Thursday on U.S. charges he participated in a scheme to bribe doctors to prescribe a fentanyl-based cancer pain drug, marking a step by authorities to fight the opioid epidemic. John Kapoor, Insys’ majority shareholder who stepped down as chief executive in January, was charged…

    Arizona Accuses Insys of Fraudulent Opioid Marketing Scheme

    (Reuters)—Arizona’s attorney general sued Insys Therapeutics Inc on Thursday, accusing the drugmaker of engaging in a fraudulent marketing scheme aimed at increasing sales of a fentanyl-based cancer pain medicine. The lawsuit by Arizona Attorney General Mark Brnovich in Maricopa County Superior Court in Phoenix comes during a series of federal and state investigations centered on…

    New Jersey Sues Insys as Opioid Maker Settles with Massachusetts

    BOSTON (Reuters)—New Jersey on Thursday accused Insys Therapeutics Inc of engaging in a fraudulent scheme to boost sales of a fentanyl-based cancer pain drug, as Massachusetts announced a $500,000 settlement with the drugmaker to resolve similar allegations. The lawsuit by New Jersey Attorney General Christopher Porrino accused Insys of illegally directing its sales force to…